PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 2 filers reported holding PTC THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264 | +1289.5% | 11,800 | +2437.6% | 0.12% | +1060.0% |
| Q2 2023 | $19 | -91.9% | 465 | -92.4% | 0.01% | -93.7% |
| Q4 2022 | $234 | -99.8% | 6,132 | +106.5% | 0.16% | -50.0% |
| Q2 2022 | $118,000 | +76.1% | 2,969 | +124.9% | 0.32% | +310.4% |
| Q3 2021 | $67,000 | -94.4% | 1,320 | -95.0% | 0.08% | -83.0% |
| Q2 2020 | $1,197,000 | +2502.2% | 26,434 | +2471.4% | 0.45% | +502.7% |
| Q1 2020 | $46,000 | -40.3% | 1,028 | -36.3% | 0.08% | -15.7% |
| Q4 2019 | $77,000 | -93.2% | 1,613 | -93.6% | 0.09% | -86.0% |
| Q2 2019 | $1,130,000 | – | 25,114 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |